Multiple cancer studies show that METTL3-installed m6A marks on SLC7A11 can be read by IGF2BP proteins to stabilize the cystine transporter transcript, elevate glutathione synthesis, and suppress ferroptosis, and FTO likewise protects colorectal tumors by sustaining SLC7A11/GPX4 expression. This evidence concerns the gene FTO and cancer.